IPOpulse
Sign up
Back to Ticker

Alivus Life Sciences Limited

NSE: ALIVUS
₹1,268.6
-3.12%EOD · 19 Oct
Market Cap
₹15,575 Cr
52W Range
₹1494 / ₹819
Volume
136K
58.4% delivery
1Y Return
+35.9%
P/E Ratio
26.7
P/B Ratio
4.8
ROE
18.4%
Debt / Equity
1.70

Quality Score

Durability · Valuation · Momentum — objective math, not advice
B
69/100
Composite score: 40% quality, 30% valuation, 30% momentum
QualityGood · 68
ValuationAverage · 45
MomentumStrong · 95
In confirmed uptrend (Stage 2)

Technical Indicators

Full analysis · objective math, not advice
Returns
1D
-3.1%
1W
-5.7%
1M
-8.6%
3M
+12.0%
6M
+18.6%
1Y
+35.9%
Weinstein Stage
Stage 2 — Advancing (uptrend)
RSI (14)
32 Neutral
Trend Template
6/7strong
RS vs Nifty (3M)
+15.3pp
Moving Averages (price vs MA)
20-DMA
₹1355
below
50-DMA
₹1370
below
150-DMA
₹1172
above
200-DMA
₹1106
above
From 52W High
-15.1%
From 52W Low
+54.9%
Support (20D)
₹1256
Resistance (20D)
₹1446

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

Sign in to join the discussion.

Sign in

No comments yet — be the first to share your view.